正在加载视频...

视频加载失败

NAD+ has been studied since 1906. It has 2 Nobel Prizes, randomized human trials, and over a century of biochemistry behind it. Yet in 2017, the FDA advisory committee voted against adding it to the 503A bulks list. The reason wasn't what most people think.

45,084 次观看 • 1 个月前 •via X (Twitter)

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频